December 03, 2019: Today, in Delhi, Dr Harsh Vardhan launched a new generation vaccine against rotavirus ‘ROTAVAC 5D’ developed under a Public private partnership (PPP) model involving Department of Biotechnology and Bharat Biotech International Limited. This occasion also marks the achievement of 100M doses of worldwide supplies of ROTAVAC vaccine.

ROTAVAC 5D’ has been evaluated in clinical trials in India & other countries. It is safe & affordable, besides being cross-protective against a variety of rotavirus strains. Rotavirus Diarrhoea causes more than 120,000 infant deaths in India annually.

Dr Harsh Vardhan emphasized upon the need to improve immunization coverage in the country, by reaching out to ‘the unreached’ & motivating them for full immunization. We should aim to ensure that not even one child dies of a vaccine preventable disease.

Science has the power, potential & ability to solve every problem that human beings still encounter on this planet. Everything is possible through right application of science & thinking in the right direction.

Also present were Dr Krishna Ella, CMD Bharat Biotech, Dr Roger Glass, Director Fogarty International NIH, Ms Aurelia Nguyen GAVI Director, Dr Mathurram Santosham, John Hopkins University, and Director for American Health